A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer
Clinical trial NCT04908787 · COMPLETED
Trial details
- NCT number
- NCT04908787
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2023-12-08
- Enrollment
- 421
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.